http://www.enterpriseeuropeni.com/inx/assets/images/sitelook/een.gif Fri, 3 Feb 2012 00:00:01 GMT Technology collaboration - 11 IT 52T6 3KYQ OFFER

An Italian company dealing with design,development and production of micro and nanofluidic for biological and medical applications such as separation,preconcentration,detection of biomolecules(proteins and DNA) has developed innovative nanofabrication technologies. Such solutions can be easily integrated in more complex platforms and allow the production of low cost nanostructured devices. The company is looking for joint further development, testing of new applications and financial resources.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=11 IT 52T6 3KYQ&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=11 IT 52T6 3KYQ&EnquiryType=BBS Thu, 2 Feb 2012 00:00:02 GMT Technology collaboration - 12 TR 99PB 3O03 OFFER

A Turkish company specialized in the manufacturing of pathology and microbiology equipments developed a dispensing device for obtaining formalin in a given concentrate. This device can be used in every laboratory using formalin such as pathology, histology laboratories and it prevents the harmful effects of formalin to human health. The company is looking for commercial agreement with technical assistance to adapt the device to partners needs.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 TR 99PB 3O03&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 TR 99PB 3O03&EnquiryType=BBS Wed, 1 Feb 2012 00:00:03 GMT Technology collaboration - 12 HU 50S0 3NZ2 REQUEST

A Hungarian small enterprise is searching for a production line, with which it is possible to produce protein and/or sugar from vegetable basic commodities in a system connected to bio-gas works. The company is involved in projects dealing with bio-refinement, and it also possesses knowledge on agriculture and environment protection. The technology is ready for demonstration, or it can also appear on the market. Industrial companies can be partners.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 HU 50S0 3NZ2&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 HU 50S0 3NZ2&EnquiryType=BBS Tue, 31 Jan 2012 00:00:04 GMT Technology collaboration - 12 LU 87GA 3NZZ REQUEST

A large US company is looking for proposals for validated in vivo models able to link inhibition of autotoxin (ATX) activity and decline of lysophosphatidic acid (LPA) levels to the reduction of clinically relevant biomarkers, preferably, but not limited to oncology, immune-mediated diseases, or fibrosis. They are interested in contract research, joint development license agreement.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 LU 87GA 3NZZ&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 LU 87GA 3NZZ&EnquiryType=BBS Fri, 27 Jan 2012 00:00:05 GMT Technology collaboration - 12 DE 1380 3O09 OFFER

A large German Research Institute has investigated and elucidated the effect of receptor-tyrosine kinase inhibitors which inhibit uncontrolled cell replications and other diseases caused by receptor-tyrosin kinase. This inhibitor is applicable in biotechnology or pharmaceutical industry. The institute seeks either a license agreement or a joint further development.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 DE 1380 3O09&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 DE 1380 3O09&EnquiryType=BBS Fri, 27 Jan 2012 00:00:06 GMT Technology collaboration - 12 ES 24D4 3O0Y OFFER

A Spanish university research group has developed a technology related to a process for the selection of neuronal cells in culture in terms of their differentiation, through the establishment of a dose-response relation by adding different concentrations of flubendiamide to several groups of nerve cells. Companies from agribusiness, chemical or pharmaceutical fields, and in antitumor or neuro-regenerative therapies, are sought for license agreements.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 ES 24D4 3O0Y&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 ES 24D4 3O0Y&EnquiryType=BBS Fri, 27 Jan 2012 00:00:07 GMT Technology collaboration - 12 IL 80EP 3O1C REQUEST

An Israeli clinical stage biotechnology company is looking for a partner to collaborate on developing its lead compound, a short peptide antagonist of CD28, for treatment of immune related diseases. The company is seeking to collaborate with service providers, academic researchers and clinical investigators in the fields of drug development (preclinical and clinical) in the area of Cardiovascular Ischemia reperfusion injury and multiple myeloma.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 IL 80EP 3O1C&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 IL 80EP 3O1C&EnquiryType=BBS Thu, 26 Jan 2012 00:00:08 GMT Technology collaboration - 11 DE 093I 3NFX OFFER

A SME from Saxony specialized in PCR (Polymerase Chain Reaction), elektrophoresis, bio-imaging, and radioanalystics is offering technical cooperation for innovative implementation of PC-controled gel domcumentation systems. R&D processes and results assure new dimensions of transparency. The improvement of existing quality control management systems is offered via a Commercial Agreement with Technical Assistance.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=11 DE 093I 3NFX&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=11 DE 093I 3NFX&EnquiryType=BBS Thu, 26 Jan 2012 00:00:09 GMT Technology collaboration - 11 DE 093I 3NFZ REQUEST

A SME from Saxony specialized in PCR (Polymerase Chain Reaction), elektrophoresis, bio-imaging, and radioanalystics is requesting joint further development and is looking for partners interested in open innovation solutions and product-evolution of PC-controlled gel domcumentation systems. The creation of new market applications should focus on product development in the field of OEM (Original Equimpment Manufacturing).]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=11 DE 093I 3NFZ&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=11 DE 093I 3NFZ&EnquiryType=BBS Thu, 26 Jan 2012 00:00:10 GMT Technology collaboration - 12 ES 23D2 3NYW OFFER

A Spanish research group has developed a new generation of biomarkers based on magnetic and fluorescent properties. The hybrid bio-particles can be used for cell imaging and monitoring, drug delivery and biomarking according to specific requirements. The process is fully developed, patented and lab tests are available. The research group is looking for companies acquiring this technology for its exploitation, although it is open to other kind of collaboration.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 ES 23D2 3NYW&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 ES 23D2 3NYW&EnquiryType=BBS Wed, 25 Jan 2012 00:00:11 GMT Technology collaboration - 12 ES 27F4 3NXY OFFER

An Andalucian research group has developed and patented a technology for obtaining animal cell lines resistant to cytotoxic drugs that act by inhibiting the vacuolar ATPase. These cell lines may be the basis for restoring tissues and organs damaged by chemotherapy. Industrial partners interested in a patent license for the exploitation of the technology are sought.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 ES 27F4 3NXY&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 ES 27F4 3NXY&EnquiryType=BBS Wed, 25 Jan 2012 00:00:12 GMT Technology collaboration - 12 ES 28G2 3NY3 OFFER

A Spanish public research organisation has devised a minimal system for in vitro terminal protein (TP)-primed amplification of lineal DNA. A 69-194 nucleotide sequence of the phage Phi29 DNA is attached to each end of the lineal DNA and high fidelity DNA copies, linked to TP are synthesized by adding Phi29 TP, DNA polymerase and two DNA binding proteins. Besides, TP-DNA is itself useful for protein-DNA applications. They look for biotechs to sell DNA-amplification kits under a patent licence.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 ES 28G2 3NY3&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 ES 28G2 3NY3&EnquiryType=BBS Tue, 24 Jan 2012 00:00:13 GMT Technology collaboration - 12 DE 1486 3NWJ OFFER

A technology transfer office in Bavaria represents a known German university. Its Institute of Molecular Virology focuses on intracellular signal transduction pathways and their impact on viral infection and inflammation. The investigators could show that the attenuation of influenza A viruses (IAV) by introduction of silent mutations into the nucleoprotein (NP) gene may serve as a strategy for a live attenuated vaccine. We are looking for a licensee.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 DE 1486 3NWJ&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 DE 1486 3NWJ&EnquiryType=BBS Tue, 24 Jan 2012 00:00:14 GMT Technology collaboration - 12 GB 41n7 3NX8 REQUEST

A UK company supplies cleaning solutions in medical, commercial and consumer markets. They are looking for partnerships to develop further proven approaches to control spore forming Clostridium difficile in its spore form. (May include solutions against Bacillus spp. that are likely to work). Type of collaboration may vary and depends on the stage of development. The UK company has funding for development and eventual launch on global markets.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 GB 41n7 3NX8&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 GB 41n7 3NX8&EnquiryType=BBS Mon, 23 Jan 2012 00:00:15 GMT Technology collaboration - 11 ES 23C7 3NSI OFFER

Listeria monocytogenes has been one of the greatest safety concerns for food industry in the last decades. A Spanish SME has developed two instruments that improve the performance of the methods used nowadays for sampling and detection of the bacterium on surfaces. The SME seeks industrial partners for a technical cooperation agreement with the purpose of testing and adapting the instruments to the requirements of different sectors.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=11 ES 23C7 3NSI&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=11 ES 23C7 3NSI&EnquiryType=BBS Mon, 23 Jan 2012 00:00:16 GMT Technology collaboration - 12 FR 33j7 3NWC OFFER

A French SME has developed and patented a new method to detect micro-organisms and in particular moulds resistant to fungicides. This method is based on a standardised lab method and an image analysis technology. By taking pictures, different parameters are measured to allow a classification of the type of resistance. Based on licensing agreement, the SME is looking for a partner which could integrate this technology to complete its offer in microbiology.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 FR 33j7 3NWC&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 FR 33j7 3NWC&EnquiryType=BBS Mon, 23 Jan 2012 00:00:17 GMT Technology collaboration - 12 IT 56Z6 3NWB OFFER

A research institute in the North of Italy patented an invention related to the medical and pharmacological field, in particular to the treatment of HIV/AIDS infection. In particular, the patent relates to the discovery that certain peptides can target one of the HIV-1 proteins, Tat and block its function. The Tat protein acts as an essential activator of viral gene expression and replication. They are looking for potential licensees interested in the technology.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 IT 56Z6 3NWB&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 IT 56Z6 3NWB&EnquiryType=BBS Mon, 23 Jan 2012 00:00:18 GMT Technology collaboration - 12 IT 56Z6 3NWD OFFER

A research group from North of Italy developed an invention related to the medical field, in particular to the treatment and diagnosis of cancer. More in particular, it relates to the use of polyallylamine with positive net charge as anticancer agent and as diagnostic agent for the detection and/or treatment of cancer cells in body tissues. According to the present invention, polyallylamine is useful as a theranostic agent. They are searching for licence agreement collaborations.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 IT 56Z6 3NWD&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 IT 56Z6 3NWD&EnquiryType=BBS Mon, 23 Jan 2012 00:00:19 GMT Commercial partnering opportunity - 20120123030

]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=20120123030&EnquiryType=BCD http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=20120123030&EnquiryType=BCD Thu, 19 Jan 2012 00:00:20 GMT Technology collaboration - 12 HU 5010 3NV9 OFFER

A leading biotechnology SME in Hungary, offers the ability to create transgenic rabbit and rat models via microinjecting large genomic fragments at its state-of-the-art facility. Proven track record with some of the world's leading developers of rabbit and rat models. The technology ensures high level tissue and developmental stage specific expression of the transgene. Pharma manufacturers and R&D partners are sought for technical cooperation, commercial or manufacturing agreements.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 HU 5010 3NV9&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 HU 5010 3NV9&EnquiryType=BBS Thu, 19 Jan 2012 00:00:21 GMT Technology collaboration - 12 HU 50S2 3NVI OFFER

The Hungarian SME dealing with bioenergetics, climate and environmental protection offers an integrated system. The combination of renewable energetic, biotechnological, climate change and environmental protection processes are adaptable to greenhouse gas conversion necessity, territorial conditions and specific needs. Main advantages of the system are zero carbon emission and economic efficiency. The company is looking for investors, financial and technical+commercial cooperation partners.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 HU 50S2 3NVI&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 HU 50S2 3NVI&EnquiryType=BBS Thu, 19 Jan 2012 00:00:22 GMT Commercial partnering opportunity - 20120119008

]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=20120119008&EnquiryType=BCD http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=20120119008&EnquiryType=BCD Thu, 19 Jan 2012 00:00:23 GMT Commercial partnering opportunity - 20120119011

]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=20120119011&EnquiryType=BCD http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=20120119011&EnquiryType=BCD Tue, 17 Jan 2012 00:00:24 GMT Technology collaboration - 12 DE 1380 3NWI OFFER

A large German Research Institute has developed a micromixer for quantitatively small reactors which is usable for effective mixing of liquids in microflows. Due to the small dead volumes this technology is especially applicable in microbiology, chemistry, pharmaceutical industry or microtechnology. The institute seeks either a license agreement or a partner for joint further development.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 DE 1380 3NWI&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 DE 1380 3NWI&EnquiryType=BBS Tue, 17 Jan 2012 00:00:25 GMT Technology collaboration - 12 DE 1380 3NXG OFFER

A large German Research Institute has developed a new biological ink for dip-pen nanolithography (DPN) which is a method of surface structuring. Due to this technology phospholipids can now be used as a universal ink for Dip-Pen Nanolithography on a variety of substrates. A wide range of application is provided by this newly developed ink, e.g. in pharmaceutical industry, biotechnology or nanofabrication. The institute seeks either a license agreement or a technical cooperation.]]> http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 DE 1380 3NXG&EnquiryType=BBS http://www.enterpriseeuropeni.com/inx/rss/clickHandler.asp?mi=140&id=12 DE 1380 3NXG&EnquiryType=BBS